Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2025 Earnings Call Transcript November 5, 2025
Cytek Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.04295 EPS, expectations were $0.01.
Operator: Good day, everyone, and thank you for standing by. My name is Arjarie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Cytek Biosciences Third Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to turn...
